Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ
Keiji Tanese(Toho University), Elizabeth A. Grimm(The University of Texas MD Anderson Cancer Center), Sühendan Ekmekçioglu(The University of Texas MD Anderson Cancer Center), Felipe Samaniego(The University of Texas MD Anderson Cancer Center), Yuling Wang(The University of Texas MD Anderson Cancer Center), Yuuri Hashimoto(Daiichi-Sankyo (Japan)), Jeffrey E. Lee(The University of Texas MD Anderson Cancer Center), Zuzana Berkova(The University of Texas MD Anderson Cancer Center)
Cited by 23
Related Papers
Detectable clonal mosaicism from birth to old age and its relationship to cancer
|Nature Genetics|2012|598
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
|Nature Medicine|2020|593
Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experience
|British Journal of Haematology|2014|364
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
|Cancer Cell|2022|338
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
|The Lancet Oncology|2014|263